Therapeutic Approaches to HAART-induced Lipodystrophy.
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2013 Planned end date changed from 1 Sep 2014 to 1 Sep 2016 as reported by ClinicalTrials.gov.